Aclaris Therapeutics, Inc. (ACRS)
NASDAQ·Healthcare·Biotechnology
$5.31
-3.45%
Mkt Cap $768.85M
Analyst Ratings
Buy
4
Hold
0
Sell
0
Price Target (9 analysts)
$10.75
Range $10.00 – $12.00
Implied Upside
+102.6%
Consensus $10.75 vs current $5.31
NASDAQ·Healthcare·Biotechnology
$5.31
-3.45%
Mkt Cap $768.85M
Buy
4
Hold
0
Sell
0
Price Target (9 analysts)
$10.75
Range $10.00 – $12.00
+102.6%
Consensus $10.75 vs current $5.31